Willems, P.

inhibitor patient quantitation tumor probe kinase dilution epo-induced erythroid myeloma phosphorylation tumor cells blood asopcr assay jak 2 consensus binding pkc inhibitors variation pi 3k activation differentiation sample activity product dilution assay erythroid progenitors result sequence protein control center number coefficient variation coefficient multicenter marrow progenitors myeloma tumor cells pcr product study erythroid cells ly 294002 vh 3fr probe presence inhibition pkc ␣ effect primers figure pcr intra pcr strategy receptor igh asopcr epo-induced phosphorylation consensus strategy ag 490 intra value amount patient h 109203x erasmus mc condition kinase activity cycle antibody amplification tyrosine myeloma patients renewal asopcr product polymerase concentration reproducibility lysate target addition method